Codrituzumab-MMAE (ADC)

• Description :

  Codrituzumab-MMAE is an ADC consisting of a GPC3-directed antibody and Monomethyl auristatin E (MMAE) used for the study of hepatocellular carcinoma.

• Reactivity :

  Human

• Applications :

  Research Grade Biosimilar

• Stability :

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.

• Endotoxin :

  Please contact with the lab for this information.

• Purity :

  >90% as determined by SEC.

• Form :

  Liquid

• Notes :

  For research use only. Not suitable for clinical or therapeutic use.